Ryan Tunis
Stock Analyst at Cantor Fitzgerald
(2.22)
# 2,805
Out of 5,241 analysts
58
Total ratings
48%
Success rate
-1.89%
Average return
Main Sectors:
Stocks Rated by Ryan Tunis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CB Chubb | Reiterates: Neutral | $315 | $330.33 | -4.64% | 2 | Apr 22, 2026 | |
| WTW Willis Towers Watson | Maintains: Neutral | $363 → $354 | $256.86 | +37.82% | 2 | Apr 9, 2026 | |
| WRB W. R. Berkley | Downgrades: Neutral | $75 → $71 | $68.76 | +3.26% | 3 | Apr 9, 2026 | |
| TRUP Trupanion | Maintains: Neutral | $42 → $34 | $22.45 | +51.45% | 2 | Apr 9, 2026 | |
| RYAN Ryan Specialty Holdings | Maintains: Neutral | $45 → $40 | $33.67 | +18.80% | 3 | Apr 9, 2026 | |
| RNR RenaissanceRe Holdings | Upgrades: Overweight | $306 → $340 | $298.40 | +13.94% | 2 | Apr 9, 2026 | |
| KNSL Kinsale Capital Group | Maintains: Neutral | $360 → $280 | $324.77 | -13.79% | 3 | Apr 9, 2026 | |
| HIG The Hartford Insurance Group | Maintains: Overweight | $165 → $160 | $136.56 | +17.16% | 8 | Apr 9, 2026 | |
| GSHD Goosehead Insurance | Maintains: Overweight | $84 → $67 | $42.14 | +58.99% | 2 | Apr 9, 2026 | |
| AIG American International Group | Maintains: Neutral | $77 → $81 | $78.36 | +3.37% | 6 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $97 → $100 | $95.87 | +4.31% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $220 | $221.21 | -0.55% | 4 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $316 → $319 | $305.99 | +4.25% | 5 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $212 | $165.98 | +27.73% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $393 → $412 | $326.57 | +26.16% | 2 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $92 | $54.48 | +68.87% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $348 → $344 | $355.82 | -3.32% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $344 → $282 | $207.15 | +36.13% | 3 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $204.00 | -58.33% | 6 | Oct 18, 2019 |
Chubb
Apr 22, 2026
Reiterates: Neutral
Price Target: $315
Current: $330.33
Upside: -4.64%
Willis Towers Watson
Apr 9, 2026
Maintains: Neutral
Price Target: $363 → $354
Current: $256.86
Upside: +37.82%
W. R. Berkley
Apr 9, 2026
Downgrades: Neutral
Price Target: $75 → $71
Current: $68.76
Upside: +3.26%
Trupanion
Apr 9, 2026
Maintains: Neutral
Price Target: $42 → $34
Current: $22.45
Upside: +51.45%
Ryan Specialty Holdings
Apr 9, 2026
Maintains: Neutral
Price Target: $45 → $40
Current: $33.67
Upside: +18.80%
RenaissanceRe Holdings
Apr 9, 2026
Upgrades: Overweight
Price Target: $306 → $340
Current: $298.40
Upside: +13.94%
Kinsale Capital Group
Apr 9, 2026
Maintains: Neutral
Price Target: $360 → $280
Current: $324.77
Upside: -13.79%
The Hartford Insurance Group
Apr 9, 2026
Maintains: Overweight
Price Target: $165 → $160
Current: $136.56
Upside: +17.16%
Goosehead Insurance
Apr 9, 2026
Maintains: Overweight
Price Target: $84 → $67
Current: $42.14
Upside: +58.99%
American International Group
Feb 17, 2026
Maintains: Neutral
Price Target: $77 → $81
Current: $78.36
Upside: +3.37%
Feb 17, 2026
Maintains: Neutral
Price Target: $97 → $100
Current: $95.87
Upside: +4.31%
Feb 5, 2026
Reiterates: Neutral
Price Target: $220
Current: $221.21
Upside: -0.55%
Feb 2, 2026
Maintains: Overweight
Price Target: $316 → $319
Current: $305.99
Upside: +4.25%
Feb 2, 2026
Maintains: Overweight
Price Target: $208 → $212
Current: $165.98
Upside: +27.73%
Feb 2, 2026
Maintains: Overweight
Price Target: $393 → $412
Current: $326.57
Upside: +26.16%
Jan 14, 2026
Maintains: Overweight
Price Target: $85 → $92
Current: $54.48
Upside: +68.87%
Jan 14, 2026
Maintains: Neutral
Price Target: $348 → $344
Current: $355.82
Upside: -3.32%
Jan 14, 2026
Downgrades: Neutral
Price Target: $344 → $282
Current: $207.15
Upside: +36.13%
Oct 18, 2019
Maintains: Outperform
Price Target: $90 → $85
Current: $204.00
Upside: -58.33%